Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-721-1443
Dr. Anand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 2009 - 2012
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2009
- Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2010 - 2026
- NY State Medical License 2009 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Comparing Diuretic Strategies in Hospitalized Heart Failure Start of enrollment: 2023 Jul 01
- SARS-COV-2 Screening in Dialysis Facilities Start of enrollment: 2023 Feb 06
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsGlucarpidase for treatment of high-dose methotrexate toxicity.Shruti Gupta, Sarah A Kaunfer, Kevin L Chen, Julie-Alexia Dias, Anitha Vijayan
Blood. 2025-04-24 - Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19.Marimar Contreras Nieves, Shuchi Anand, I-Chun Thomas, Pascal Geldsetzer, Enrica Fung
American Journal of Kidney Diseases. 2025-04-07 - BPROAD - End of the Road for Debate on Systolic Blood-Pressure Goals in Type 2 Diabetes?Shuchi Anand, Srinivasan Beddhu
The New England Journal of Medicine. 2025-03-27
Journal Articles
- Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient SampleShuchi Anand, Glenn M Chertow, Journal of General Internal Medicine
Press Mentions
- Regular SARS-CoV-2 Testing in Hemodialysis Facilities Unacceptable to Most PatientsOctober 1st, 2024
- SARS-CoV-2 Seroprevalence in Dialysis Patients 1-Year After COVID-19 Pandemic OnsetDecember 1st, 2021
- J&J Coronavirus Vaccine Produces Low Antibody Response, Study FindsOctober 15th, 2021
- Join now to see all
Grant Support
- Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocationSTANFORD UNIVERSITY2023–2025
- Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocationSTANFORD UNIVERSITY2023–2025
- Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocationSTANFORD UNIVERSITY2023–2025
- Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
- Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
- Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
- Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
- Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
- Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
- Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: